SE442266B - Transdermalt medicineringssystem for isosorbiddinitrat och sett for framstellning derav - Google Patents

Transdermalt medicineringssystem for isosorbiddinitrat och sett for framstellning derav

Info

Publication number
SE442266B
SE442266B SE8001599A SE8001599A SE442266B SE 442266 B SE442266 B SE 442266B SE 8001599 A SE8001599 A SE 8001599A SE 8001599 A SE8001599 A SE 8001599A SE 442266 B SE442266 B SE 442266B
Authority
SE
Sweden
Prior art keywords
water
carbon atoms
fatty acid
weight
solvent
Prior art date
Application number
SE8001599A
Other languages
English (en)
Swedish (sv)
Other versions
SE8001599L (sv
Inventor
G Cordes
E Giesselmann
U Munch
Original Assignee
Sanol Arznei Schwarz Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanol Arznei Schwarz Gmbh filed Critical Sanol Arznei Schwarz Gmbh
Publication of SE8001599L publication Critical patent/SE8001599L/
Publication of SE442266B publication Critical patent/SE442266B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE8001599A 1979-06-13 1980-02-29 Transdermalt medicineringssystem for isosorbiddinitrat och sett for framstellning derav SE442266B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2924005A DE2924005C2 (de) 1979-06-13 1979-06-13 Isosorbiddinitrat enthaltendes Mittel

Publications (2)

Publication Number Publication Date
SE8001599L SE8001599L (sv) 1980-12-14
SE442266B true SE442266B (sv) 1985-12-16

Family

ID=6073179

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8001599A SE442266B (sv) 1979-06-13 1980-02-29 Transdermalt medicineringssystem for isosorbiddinitrat och sett for framstellning derav

Country Status (24)

Country Link
US (1) US4293565A (fi)
JP (1) JPS55167216A (fi)
AR (1) AR222527A1 (fi)
AT (1) AT365451B (fi)
AU (1) AU530739B2 (fi)
BE (1) BE881382A (fi)
CA (1) CA1118351A (fi)
CH (1) CH643456A5 (fi)
DE (1) DE2924005C2 (fi)
DK (1) DK528879A (fi)
ES (1) ES8100883A1 (fi)
FI (1) FI69753C (fi)
FR (1) FR2458285A1 (fi)
GB (1) GB2050827B (fi)
GR (1) GR70373B (fi)
IE (1) IE49527B1 (fi)
IT (1) IT1140521B (fi)
LU (1) LU81902A1 (fi)
NL (1) NL8000129A (fi)
NO (1) NO801710L (fi)
PT (1) PT70696A (fi)
SE (1) SE442266B (fi)
YU (1) YU308379A (fi)
ZA (1) ZA796256B (fi)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK243084A (da) * 1983-05-26 1984-11-27 Takeda Chemical Industries Ltd Perkutane farmaceutiske praeparater til udvortes brug
DE3325466A1 (de) * 1983-07-14 1985-01-24 Mack Chem Pharm Pharmazeutische zubereitung enthaltend isosorbiddinitrat
US4632937A (en) * 1984-12-21 1986-12-30 Ici Americas Dentifrice formulation and method of treating teeth, mouth and throat therewith to reduce plaque accumulation and irritation
DE3613187A1 (de) * 1986-04-18 1987-10-22 Mack Chem Pharm Verwendung einer carbonsaeure in zur topischen anwendung bestimmten pharmazeutischen zubereitungen
US5227157A (en) * 1986-10-14 1993-07-13 Board Of Regents, The University Of Texas System Delivery of therapeutic agents
US4804541A (en) * 1987-08-11 1989-02-14 Moleculon, Inc. Transdermal administration using benzyl alcohol
US5035886A (en) * 1987-10-19 1991-07-30 Ppg Industries, Inc. Active agent delivery device
US4959208A (en) * 1987-10-19 1990-09-25 Ppg Industries, Inc. Active agent delivery device
US5505963A (en) * 1993-04-07 1996-04-09 Schwartz Pharma Ag Slow release pharmaceutical preparation
GB9711032D0 (en) * 1997-05-30 1997-07-23 Johnson Matthey Plc Compound as a stimulant for the central nervous system
US6465463B1 (en) * 1999-09-08 2002-10-15 Nitromed, Inc. Methods of treating and preventing congestive heart failure with hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate
US7537785B2 (en) * 1999-10-29 2009-05-26 Nitromed, Inc. Composition for treating vascular diseases characterized by nitric oxide insufficiency
US7235237B2 (en) * 1999-10-29 2007-06-26 Nitromed, Inc. Methods of treating vascular diseases characterized by nitric oxide insufficiency
US7708989B2 (en) * 1999-10-29 2010-05-04 Nitromed, Inc. Methods of treating vascular diseases characterized by nitric oxide insufficiency
DE60042611D1 (de) * 1999-10-29 2009-09-03 Nitromed Inc Verfahren zur behandlung von gefässerkrankungen, dxid auszeichnen
US6479060B1 (en) 2001-09-04 2002-11-12 Healthpoint, Ltd. Elegant hydrogenated castor oil ointments
US7439241B2 (en) * 2003-05-27 2008-10-21 Galderma Laboratories, Inc. Compounds, formulations, and methods for treating or preventing rosacea
EP1984010A4 (en) * 2006-02-17 2010-09-08 Nitromed Inc METHOD FOR USE OF HYDRALAZIN COMPOUNDS AND ISOSORBIDE DINITRATE OR ISOSORBIDE MONONITRATE
EP2024337A4 (en) * 2006-05-16 2011-09-14 Nitromed Inc SOLID DOSAGE FORMULATIONS OF HYDRALAZIN COMPOUNDS
US8496917B2 (en) * 2009-11-13 2013-07-30 Sytheon Ltd Compositions and methods for improving skin appearance

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA715659B (en) * 1970-10-02 1972-04-26 Syntex Corp Fatty-alcohol propylene glycol cosolvent vehicle
BE790136R (fr) * 1971-11-29 1973-02-15 Esteve Labor Dr Nouveaux esters et hemi-esters des acides dicarboxyliques et procede depreparation de ces
FR2379285A2 (fr) * 1977-02-08 1978-09-01 Expl Marques Brevets Et Nouvelle composition a base d'acide salicylique et de corticoide
US4112115A (en) * 1976-11-08 1978-09-05 Coghlan Charles C Therapy of leg muscle cramps

Also Published As

Publication number Publication date
JPS6321648B2 (fi) 1988-05-09
ATA809079A (de) 1981-06-15
GB2050827B (en) 1983-04-20
IT1140521B (it) 1986-10-01
DK528879A (da) 1980-12-14
FR2458285A1 (fr) 1981-01-02
CA1118351A (en) 1982-02-16
CH643456A5 (de) 1984-06-15
FI69753B (fi) 1985-12-31
FI794003A (fi) 1980-12-14
ES8100883A1 (es) 1981-03-01
FI69753C (fi) 1986-05-26
ZA796256B (en) 1980-10-29
AU5445880A (en) 1980-12-18
DE2924005A1 (de) 1980-12-18
GR70373B (fi) 1982-09-30
PT70696A (en) 1980-02-01
BE881382A (fr) 1980-05-16
GB2050827A (en) 1981-01-14
SE8001599L (sv) 1980-12-14
AT365451B (de) 1982-01-25
IT8019266A0 (it) 1980-01-17
IE800406L (en) 1980-12-13
YU308379A (en) 1988-04-30
DE2924005C2 (de) 1984-07-05
AU530739B2 (en) 1983-07-28
NL8000129A (nl) 1980-12-16
ES487833A0 (es) 1980-12-16
AR222527A1 (es) 1981-05-29
LU81902A1 (de) 1980-04-22
US4293565A (en) 1981-10-06
NO801710L (no) 1980-12-15
JPS55167216A (en) 1980-12-26
IE49527B1 (en) 1985-10-16
FR2458285B1 (fi) 1983-04-22

Similar Documents

Publication Publication Date Title
SE442266B (sv) Transdermalt medicineringssystem for isosorbiddinitrat och sett for framstellning derav
KR101409792B1 (ko) 항진균성 약제학적 조성물
US4153689A (en) Stable insulin preparation for nasal administration
JP5688405B2 (ja) 抗真菌医薬組成物
DE60204322T2 (de) Stickstoffmonoxid bildende zusammensetzungen zur behandlung von nagelbettinfektionen
KR20130112727A (ko) 향진균성 약학적 조성물
TW304167B (fi)
US20020055542A1 (en) Topical aromatic fatty acid composition
GB2096890A (en) Anti-inflammatory analgesic cataplasms containing indomethacin and process for producing the same
JP2005162728A (ja) 局所用途のためのムピロシン組成物、これを作成する改良プロセス、およびこれを用いる方法
JP2557557B2 (ja) ピロキシカム含有局所投与用医薬組成物
WO2005041943A1 (en) Transdermal pharmaceutical spray formulations comprising a vp/va copolymer and a non-aqueous vehicle
WO2021204223A1 (zh) 一种包含烟酰胺的药物组合物
US20040171684A1 (en) Method for treating aberrant fibrotic tissue manifestations with topical calcium channel blocker preparations and improved composition for such treatment and improved method for the manufacture thereof
JPH01143831A (ja) 外用液剤
CN107468637A (zh) 复方他扎罗汀尿素外用制剂及其制备方法
KR101733189B1 (ko) 손톱 또는 발톱 성장 촉진용 조성물
CN107613987A (zh) 糠酸莫米松的局部喷雾组合物
JPH0157091B2 (fi)
CN116370401A (zh) 一种氨甲环酸外用制剂及其用途
JPS638331A (ja) 感染治療剤
JPH11199485A (ja) 抗真菌持続性外用剤
HU198391B (en) Process for producing pharmaceutical composition for treating psoriasis
JPS63208517A (ja) 新規なトルナフテ−ト含有液剤
KR20060136367A (ko) Ｖｐ／ｖａ 공중합체 및 비-수성 부형제를 포함하는 경피용약학적 스프레이 제제들

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8001599-3

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8001599-3

Format of ref document f/p: F